Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
My Cancer Genome
Vanderbilt University’s My Cancer Genome app provides a great deal of information related to the genetics of cancer and genetically informed cancer therapeutics. The app is divided into two sections. On the “variants” page users can browse (or search) diseases, genes, and gene variants. For example, selecting a specific disease displays a description of that type of cancer as well as a list of associated genes and variants. The other section of the app deals with drugs, allowing users to browse by drug name, drug class, or target. Unfortunately, selecting on a specific drug class (such as topoisomerase inhibitors) only directs users to a list of other drugs of that class, rather than providing additional details about the mechanism of action of that class of drug.